BIOGEN INC (IDP.DE) Stock Income Statement
FRA:IDP - Deutsche Boerse Ag - US09062X1037 - Common Stock - Currency: EUR
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.00B | 9.68B | 9.84B | 10.17B | 10.98B | |||
| Minority Interest Expense | N/A | 0.00 | -400.00K | 85.00M | -172.00M | |||
| Cost Of Goods | 2.46B | 2.21B | 2.41B | 2.28B | 2.11B | |||
| Gross Profit | 7.54B | 7.47B | 7.43B | 7.89B | 8.87B | |||
| Operating Expenses | 4.81B | 4.82B | 5.25B | 4.67B | 5.38B | |||
| Research and Development | 1.88B | 2.02B | 2.46B | 2.23B | 2.50B | |||
| Selling, General, and Administrative Expenses | 2.41B | 2.40B | 2.58B | 2.43B | 2.70B | |||
| Operating Income | 2.73B | 2.65B | 2.17B | 3.22B | 3.50B | |||
| Interest Income/Expense | -511.80M | -568.40M | -530.80M | -463.00M | -1.10B | |||
| Other Income/Expense | -29.50M | -29.60M | -3.50M | -10.00M | -6.00M | |||
| Non Recurring Items | -394.70M | -147.40M | -343.20M | 841.00M | -647.00M | |||
| Income Before Taxes | 1.80B | 1.91B | 1.30B | 3.59B | 1.75B | |||
| Income Tax | 267.20M | 273.80M | 135.30M | 633.00M | 53.00M | |||
| Net Income | 1.53B | 1.63B | 1.16B | 3.05B | 1.56B | |||
| EBITDA | 3.48B | 3.32B | 2.67B | 3.74B | 3.98B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 10.45 | 11.19 | 7.97 | 20.87 | 10.37 | |||
| Non GAAP EPS | 16.01 | 16.47 | 15.08 | 18.45 | 19.18 | |||
| Statistics | ||||||||
| Gross Profit Margin | 75.43% | 77.18% | 75.51% | 77.61% | 80.79% | |||
| Profit Margin | 15.31% | 16.87% | 11.81% | 29.95% | 14.17% | |||
| Operating Profit Margin | 27.35% | 27.40% | 22.11% | 31.69% | 31.82% | |||
All data in USD